Yurong Lai and Xiao-bo Zhong have been approved by the Board of Publications Trustees to serve as associate editors for Drug Metabolism and Disposition. Dr. Zhong and Dr. Lai have been recruiting minireviews for the journal since 2018. As associate editors, they will continue in their role as minireview editors and be able to oversee minireviews from recruitment through peer review. They will also be able to fill the role of associate editor for other manuscripts.
Dr. Lai is senior director of drug metabolism at Gilead Sciences, Inc. He worked as a leading investigator at Pfizer and BMS prior to joining Gilead. He has served on the DMD editorial board since 2016 and was a co-guest editor with Qingcheng Mao and Joanne Wang for the DMD special section on transporters in drug disposition and pharmacokinetic prediction published in May 2018. He has been an ASPET member since 2007 and has served as a councilor for the Division for Drug Metabolism and Disposition. He is a fellow of the AAPS.
Dr. Zhong is a professor in the Department of Pharmaceutical Sciences at the University of Connecticut, Storrs. He has served on the DMD editorial board since 2012 and was co-guest editor with J. Steven Leeder for the DMD special section on epigenetic regulation of drug metabolizing enzymes and transporters published in October 2013. Dr. Zhong is chair-elect of the Division for Drug Metabolism and Disposition and has been an ASPET member since 2007.